Purdue Pharma paid CEO $9M in year before bankruptcy

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company’s bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week.

Five other board members overseeing the private company were paid a combined $3.7 million over that span. In a statement Wednesday, Purdue said the pay reflects the market.

Purdue filed for bankruptcy in September as part of an effort to settle nearly 2,700 lawsuits that seek to hold the company accountable for its role in the nation’s opioid epidemic.

It is trying to reach a settlement that could be worth up to $12 billion over time.

Board chairman Steve Miller, known for helping restructure struggling companies, was brought in last year.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Trending Stories